Holen Sie sich die Stockscreener-App
7.57
0.40%
0.03
Handel nachbörslich:
7.57
Schlusskurs vom Vortag:
$7.54
Offen:
$7.6
24-Stunden-Volumen:
491.80K
Relative Volume:
0.77
Marktkapitalisierung:
$383.73M
Einnahmen:
$1.05B
Nettoeinkommen (Verlust:
$-80.50M
KGV:
-4.6728
EPS:
-1.62
Netto-Cashflow:
$44.90M
1W Leistung:
+11.82%
1M Leistung:
+7.38%
6M Leistung:
-11.87%
1J Leistung:
-14.07%
1-Tages-Spanne:
$7.541
$7.775
1-Wochen-Bereich:
$7.05
$7.9666
52-Wochen-Spanne:
$6.47
$10.90
Enhabit Inc Stock (EHAB) Company Profile
Firmenname
Enhabit Inc
Sektor
Branche
Telefon
(469) 621-6419
Adresse
6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS
Vergleichen Sie EHAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EHAB
Enhabit Inc
|
7.57 | 382.21M | 1.05B | -80.50M | 44.90M | -1.62 |
|
HCA
Hca Healthcare Inc
|
390.46 | 91.33B | 72.70B | 6.88B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
171.87 | 15.06B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.84 | 14.20B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
119.13 | 11.95B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
178.51 | 11.15B | 16.08B | 1.20B | 1.06B | 17.82 |
Enhabit Inc Stock (EHAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-14 | Hochstufung | Leerink Partners | Underperform → Market Perform |
| 2024-05-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-03-07 | Hochstufung | UBS | Sell → Neutral |
| 2023-12-12 | Eingeleitet | TD Cowen | Market Perform |
| 2023-06-20 | Eingeleitet | SVB Securities | Underperform |
| 2023-03-16 | Eingeleitet | Goldman | Neutral |
| 2022-12-13 | Eingeleitet | CJS Securities | Market Perform |
| 2022-12-08 | Eingeleitet | UBS | Sell |
| 2022-12-06 | Eingeleitet | Stifel | Buy |
| 2022-10-14 | Eingeleitet | Oppenheimer | Perform |
| 2022-08-30 | Eingeleitet | Jefferies | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-08-18 | Eingeleitet | Citigroup | Neutral |
Alle ansehen
Enhabit Inc Aktie (EHAB) Neueste Nachrichten
Enhabit CEO On Her Exit From The Company Amid ‘Challenging’ Home Health Environment - Home Health Care News
Ryan Solomon Bought 5.5% More Shares In Enhabit - 富途牛牛
Enhabit, Inc.: Hold Rating Amid Hospice Strengths and Home Health Challenges - TipRanks
Enhabit, Inc. Earnings Call: Mixed Sentiments and Strategic Moves - MSN
Enhabit, Inc. (NYSE:EHAB) Q2 2025 Earnings Call Transcript - Insider Monkey
Enhabit CEO Exits, Sees ‘Innovation, Transparency’ as Keys for Future Hospice Leaders - Hospice News
CFO’s Bold Move: Major Stock Purchase Signals Confidence in Enhabit, Inc - TipRanks
Home health deals on ice as providers weigh Medicare rate cut - Modern Healthcare
UBS Lowers Price Target for Enhabit (EHAB) to $8.50, Maintains Neutral Rating. - AInvest
UBS Lowers Enhabit Price Target to $8.50 from $10, Maintains Neutral Rating - AInvest
Enhabit’s Q2 2025 Earnings Call: Navigating Contradictions in Home Nursing Rules and Payer Contracts - AInvest
Enhabit, Inc. (EHAB): Navigating CMS Headwinds Through Operational Resilience and Strategic Deleveraging - AInvest
Enhabit Inc (EHAB): Navigating Regulatory Headwinds and Operational Leverage in a Fragmented Healthcare Market - AInvest
Enhabit, Inc. Reports Strong Q2 2025 Results - The Globe and Mail
UBS Keeps Enhabit Neutral Rating, PT Down to $8.5 from $10 - AInvest
UBS Trims Enhabit Price Target to $8.50 From $10, Maintains Neutral Rating - MarketScreener
A Quick Look at Today's Ratings for Enhabit(EHAB.US), With a Forecast Between $8.5 to $10 - 富途牛牛
Enhabit price target lowered to $8.50 from $10 at UBS - TipRanks
Enhabit, Inc: Mixed Segment Performance and Cautious Outlook Justify Hold Rating - TipRanks
Enhabit Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Pleasing Signs As A Number Of Insiders Buy Enhabit Stock - simplywall.st
Brookdale, CareTrust, Enhabit, NHI, Pennant share second-quarter earnings results - McKnight's Senior Living
Enhabit, Inc Reports Strong Q2 2025 Financial Results - The Globe and Mail
Enhabit Closes Branches, Considers More In Response To Proposed Home Health Rate - Home Health Care News
Enhabit 2025 Q2 Earnings Strong Performance as Net Income Surges 1325% - AInvest
Earnings call transcript: Enhabit Inc. Q2 2025 earnings beat boosts stock 15% - Investing.com
Earnings call transcript: Enhabit Inc. Q2 2025 earnings beat boosts stock 15% By Investing.com - Investing.com South Africa
Enhabit CEO Barb Jacobsmeyer Announces Departure - Hospice News
Transcript : Enhabit, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Enhabit reports Q2 adjusted EPS 13c, consensus 10c - TipRanks
Enhabit, Inc. shares rise 5.76% premarket after reporting strong Q2 earnings and raising annual guidance. - AInvest
Enhabit CEO Jacobsmeyer to Step Down in July 2026 - AInvest
Enhabit: Q2 Earnings Snapshot - Greenwich Time
Enhabit (EHAB) Q2 EPS Jumps 86% - The Globe and Mail
Enhabit Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Enhabit Inc. Lifts Guidance After Topping Q2 Expectations - Finimize
Enhabit (EHAB) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Enhabit's Q2 Earnings and Strategic Momentum: A High-Conviction Healthcare Play - AInvest
Enhabit Q2 2025 slides: Hospice growth offsets Home Health challenges, debt reduction continues - Investing.com
Enhabit Q2 2025 slides: Hospice growth offsets Home Health challenges, debt reduction continues By Investing.com - Investing.com South Africa
Enhabit CEO Barb Jacobsmeyer Plans To Step Down - Home Health Care News
Enhabit Q2 adjusted EPS beats expectations; raises annual guidance - MarketScreener
Enhabit, Inc Announces CEO Transition Plan - TipRanks
Enhabit CEO Jacobsmeyer to step down - TipRanks
Enhabit CEO Barb Jacobsmeyer to step down in 2026 By Investing.com - Investing.com Australia
Enhabit Q2 revenue up 6.6% YoY, increases FY23 guidance. - AInvest
Enhabit CEO Barb Jacobsmeyer to step down in 2026 - Investing.com
Enhabit Home Health & Hospice Announces CEO Transition Plan - Yahoo Finance
Favourable Signals For Enhabit: Numerous Insiders Acquired Stock - 富途牛牛
What AI tools providers are tapping to up home health efficiency - Modern Healthcare
Why Enhabit Inc. stock attracts strong analyst attentionReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Finanzdaten der Enhabit Inc-Aktie (EHAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):